Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial - Bouadma, L; Luyt, C E; Tubach, F; PRORATA trial group (Lancet, 2010)
(9713):